Should preschool wheezers ever be treated with inhaled corticosteroids?

Seminars in Respiratory and Critical Care Medicine

Volumn 28, Issue 3, 2007, Pages 272-285

  Saglani, Sejal ^a,b   Wilson, Nicola ^a,b   Bush, Andrew ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Asthma; Bronchoalveolar lavage; Endobronchial biopsy; Eosinophil; Evidence based guideline; Leukotriene receptor antagonist; Neutrophil

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CETIRIZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PREDNISOLONE;

BRONCHUS BIOPSY; CHILDHOOD DISEASE; CORTICOSTEROID THERAPY; DRUG INDICATION; EOSINOPHIL; HUMAN; IMMUNOPATHOGENESIS; LUNG LAVAGE; NEUTROPHIL; PATHOPHYSIOLOGY; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; TREATMENT PLANNING; VIRUS INFECTION; WHEEZING;

ADMINISTRATION, INHALATION; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD, PRESCHOOL; DECISION MAKING; GLUCOCORTICOIDS; HUMANS; INFANT; INFANT, NEWBORN; LEUKOTRIENE ANTAGONISTS; RESPIRATORY SOUNDS;

EID: 34250863334     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981648     Document Type: Review

References (106)

1. British Thoracic Society. Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003;58(Suppl 1):i1-i94
2. Payne D, Saglani S, Suri R, Hall P, Wilson N, Bush A. Asthma: beyond the guidelines. Curr Paediatr 2004;14: 336-346
3. Stein RT, Holberg CJ, Morgan WJ, et al. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood. Thorax 1997;52:946-952
4. Martinez FD, Morgan WJ, Wright AL, et al. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988;319: 1112-1117
5. Brooke AM, Lambert PC, Burton PR, Clarke C, Luyt DK, Simpson H. The natural history of respiratory symptoms in preschool children. Am J Respir Crit Care Med 1995;152: 1872-1878
6. Morgan WJ, Stern DA, Sherrill DL, et al. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am J Respir Crit Care Med 2005;172: 1253-1258
7. Turner SW, Palmer LJ, Rye PJ, et al. The relationship between infant airway function, childhood airway responsiveness, and asthma. Am J Respir Crit Care Med 2004;169: 921-927
8. Turner SW, Palmer LJ, Rye PJ, et al. Infants with flow limitation at 4 weeks: outcome at 6 and 11 years. Am J Respir Crit Care Med 2002;165:1294-1298
9. Lowe LA, Simpson A, Woodcock A, Morris J, Murray CS, Custovic A. NAC Manchester Asthma and Allergy Study Group. Wheeze phenotypes and lung function in preschool children. Am J Respir Crit Care Med 2005;171: 231-237
10. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003;349:1414-1422
11. Oswald H, Phelan PD, Lanigan A, et al. Childhood asthma and lung function in mid-adult life. Pediatr Pulmonol 1997; 23:14-20
12. Stick SM, Burton PR, Gurrin L, Sly PD, LeSouef PN. Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet 1996;348:1060-1064
13. Lodrup-Carlsen KC, Jaakkola JJ, Nafstad P, Carlsen KH. In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J 1997;10:1774-1779
14. Young S, LeSouef PN, Geelhoed GC, et al. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med 1991; 324:1168-1173
15. Gilliland FD, Gauderman WJ, Vora H, Rappaport E, Dubeau L. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am J Respir Crit Care Med 2002;166:710-716
16. Kabesch M, Hoefler C, Carr D, Leupold W, Weiland SK, von Mutius E. Glutathione S transferase deficiency and passive smoking increase childhood asthma. Thorax 2004; 59:569-573
17. Gilliland FD, Li YF, Dubeau L, et al. Effects of glutathione S-transferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 2002;166:457-463
18. Sasaki S, Kondo T, Sata F, et al. Maternal smoking during pregnancy and genetic polymorphisms in the Ah receptor, CYP1A1 and GSTM1 affect infant birth size in Japanese subjects. Mol Hum Reprod 2006;12:77-83
19. Lum S, Hoo AF, Dezateux C, et al. The association between birthweight, sex, and airway function in infants of nonsmoking mothers. Am J Respir Crit Care Med 2001; 164:2078-2084
20. Hoo AF, Stocks J, Lum S, et al. Development of lung function in early life: influence of birth weight in infants of nonsmokers. Am J Respir Crit Care Med 2004;170:527-533
21. Kedda MA, Lose F, Duffy D, Bell E, Thompson PJ, Upham J. The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population. Thorax 2005;60:211-214
22. Cleveland MG, Gorham JD, Murphy TL, et al. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996;64:1906-1912
23. Eder W, Klimecki W, Yu L, et al. Opposite effects of CD 14/-260 on serum IgE levels in children raised in different environments. J Allergy Clin Immunol 2005;116:601-607
24. Balfour-Lynn IM, Valman B, Wellings R, Webster AD, Taylor GW, Silverman M. Tumour necrosis factor α and leukotriene E4 production in wheezy infants. Clin Exp Allergy 1993;24:121-126
25. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC II, Welliver RC. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 1999;103:630-636
26. Kumlin M. Measurement of leukotrienes in the urine: strategies and application. Allergy 1997;52:124-135
27. Oommen A, Grigg J. Urinary leukotriene E4 in preschool children with acute clinical viral wheeze. Eur Respir J 2003;21:149-154
28. Oymar K. High levels of urinary eosinophil protein X in young asthmatic children predict persistent atopic asthma. Pediatr Allergy Immunol 2001;12:312-317
29. Oommen A, McNally T, Grigg J. Eosinophil activation and preschool wheeze. Thorax 2003;58:876-879
30. Oommen A, Patel R, Browning M, Grigg J. Systemic neutrophil activation in acute preschool viral wheeze. Arch Dis Child 2003;88:529-531
31. in't-Veen JC, Grootendorst DC, Bel E, et al. CD11b and L-selectin expression on eosinophils and neutrophils in blood and induced sputum of patients with asthma compared with normal subjects. Clin Exp Allergy 1998;28: 606-615
32. Grigg J, Riedler J, Robertsob CF. Bronchoalveolar lavage cellularity and soluble intercellular adhesion molecule-1 in children with colds. Pediatr Pulmonol 1999;28:109-116
33. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346:1699-1705
34. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001;164:2107-2113
35. Yasui K, Kobayashi N, Yamazaki T, et al. Neutrophilic inflammation in childhood bronchial asthma. Thorax 2005; 60:704-705
36. Villa JR, Garcia G, Rueda S, Nogales A. Serum eosinophilic cationic protein may predict clinical course of wheezing in young children. Arch Dis Child 1998;78:448-452
37. Koller DY, Wojnarowski C, Herkner KR, et al. High levels of eosinophilic cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol 1997; 99:752-756
38. Schellhase DE, Fawcett DD, Schutze GE, et al. Clinical utility of flexible bronchoscopy and bronchoalveolar lavage in young children with recurrent wheezing. J Pediatr 1998; 132:312-318
39. Krawiec ME, Westcott JY, Wei Chu H, et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. Am J Respir Crit Care Med 2001; 163:1338-1343
40. Le Bourgeois M, Goncalves M, Le Clainche L, et al. Bronchoalveolar cells in children < 3 years old with severe recurrent wheezing. Chest 2002;122:791-797
41. Marguet C, Jouen-Boedes F, Dean TP, et al. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough, or cystic fibrosis. Am J Respir Crit Care Med 1999;159:1533-1540
42. Marguet C, Dean TP, Warner JO. Soluble intercellular adhesion molecule-1 (sICAM-1) and interferon-gamma in bronchoalveolar lavage fluid from children with airway diseases. Am J Respir Crit Care Med 2000;162: 1016-1022
43. Leigh R, Belda J, Kelly MM, et al. Eosinophil cationic protein relates to sputum neutrophil counts in healthy subjects. J Allergy Clin Immunol 2000;106:593-594
44. Benson M, Strannegard IL, Strannegard O, et al. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-, IL-lfS, TNF- or neutrophils. J Allergy Clin Immunol 2000;106: 307-312
45. Balfour-Lynn IM, Valman B, Silverman M, Webster ADB. Nasal IgA response in wheezy infants. Arch Dis Child 1993;68:472-476
46. Azevedo I, de Blic J, Scheinmann P, Vargaftig BB, Bachelet M. Enhanced arachidonic acid metabolism in macrophages from wheezy infants: modulation by dexamethasone. Am J Respir Crit Care Med 1995;152:1208-1214
47. Azevedo I, de Blic J, Dumarey CH, Scheinmann P, Vargaftig BB, Bachelet M. Increased spontaneous release of tumour necrosis factor-α by alveolar macrophages from wheezy infants. Eur Respir J 1997;10:1767-1773
48. Stevenson EC, Turner G, Heaney LG, et al. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin Exp Allergy 1997;27:1027-1035
49. Saglani S, Malmstrom K, Pelkonen AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005;171:722-727
50. Saglani S, Payne DN, Nicholson AG, et al. The pathology of severe preschool wheeze. Thorax 2005;60(Suppl 11): ii5
51. Saglani S, McKenzie SA, Bush A, Payne DN. A video questionnaire identifies upper airway abnormalities in preschool children with reported wheeze. Arch Dis Child 2005; 90:961-964
52. Saglani S, Molyneux C, Gong H, et al. Ultrastructure of the reticular basement membrane in asthmatic adults children and infants. Eur Respir J 2006;28:505-512
53. Saglani S, Nicholson A, Scallan M, et al. Investigation of young children with severe recurrent wheeze: any clinical benefit? Eur Respir J 2006;27:29-35
54. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000;162:1403-1406
55. Burr ML, Merrett TG, Dunstan FD, Maguire MJ. The development of allergy in high-risk children. Clin Exp Allergy 1997;27:1247-1253
56. Cook DG, Strachan DP. Health effects of passive smoking-10: summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax 1999;54:357-366
57. Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002;57:226-230
58. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003;168: 1308-1311
59. Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005;60:282-287
60. Grigg J, Riedler J, Robertson CF. Soluble intercellular adhesion molecule-1 in the bronchoalveolar lavage fluid of normal children exposed to parental cigarette smoke. Eur Respir J 1999;13:810-813
61. Kam JC, Szefler SJ, Surs W, Sher ER, Leung DY. Combination of IL-2 and IL-4 reduces glucocorticoid receptor binding affinity and T-cell response to glucocorticoids. J Immunol 1993;151:3460-3466
62. Sulakvelidze I, Inman MD, Rerecich T, O'Byrne PM. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics. Eur Respir J 1998; 11:821-827
63. Lowe LA, Simpson A, Woodcock A, Morris J, Murray CS, Custovic A. NAC Manchester Asthma and Allergy Study Group. Wheeze phenotypes and lung function in preschool children. Am J Respir Crit Care Med 2005;171: 231-237
64. Holgate ST. Inflammation and remodelling in asthma and allied disorders: summary and conclusions. Clin Exp Allergy 2001;1:ix-xiii
65. Langley SJ, Goldthorpe S, Craven M, Woodcock A, Custovic A. Relationship between exposure to domestic allergens and bronchial hyperresponsiveness in non-sensitised, atopic asthmatic subjects. Thorax 2005;60:17-21
66. Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002;324:763-766
67. Murray CS, Poletti G, Kebadze T, et al. A study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospitalization in children. Thorax 2006;61:376-382
68. Bush A. Coughs and wheezes spread diseases: but what about the environment? Thorax 2006;61:367-369
69. Haahtela T, Jarvinen M, Kava T, et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-392
70. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-381
71. Boushey HA, Sorkness CA, King TSet alNational Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005;352:1519-1528
72. CAMP study. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 2000;343:1054-1063
73. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis 1992;146:547-554
74. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;354:1985-1997
75. Murray CS, Woodcock A, Langley SJ, Morris J, Custovic Afor the IFWIN Study Team. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy Infants (IFWIN): double blind, randomised, controlled study. Lancet 2006;368:754-762
76. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Kerrebijn KF. Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group. Eur Respir J 1994;7:63-68
77. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996;156:4422-4428
78. Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468-475
79. ETAC study group. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo controlled trial. Pediatr Allergy Immunol 1998;9:116-124
80. Bisgaard H, Nielsen KG. Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. Am J Respir Crit Care Med 2000;162:187-190
81. Bisgaard H, Zielen S, Garcia-Garcia ML, et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005;171:315-322
82. Robertson C, Price D, Henry R, et al. Short-course montelukast for intermittent asthma: a randomized controlled trial. Am J Respir Crit Care Med 2007;175: 323-329
83. Dockhorn RJ, Baumgartner RA, Leff JA, et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double-blind, placebo-controlled, three-period, crossover study in asthmatic patients. Thorax 2000;55: 260-265
84. Camargo CA Jr, Smithline HA, Malice MP, Green SA, Reiss TF. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003;167:528-533
85. Primhak RA, Smith CM, Yong SC, et al. The bronchoprotective effect of inhaled salmeterol in preschool children: a dose-ranging study. Eur Respir J 1999;13:78-81
86. Nielsen KG, Bisgaard H. Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer. Am J Respir Crit Care Med 2001;164: 256-259
87. Wilson N, Sloper K, Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch Dis Child 1995;72: 317-320
88. Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch Dis Child 1993;68: 85-87
89. Thibeault DW, Heimes B, Rezaiekhaligh M, Mabry S. Chronic modification of lung and heart development in glucocorticoid treated newborn rats exposed to hyperoxia or room air. Pediatr Pulmonol 1993;16:81-88
90. Tschanz SA, Damke BM, Burri PH. Influence of postnatally administered glucocorticoids on rat lung growth. Biol Neonate 1995;68:229-245
91. Langston C, Kida K, Reed M, Thurlbeck WM. Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 1984;129:607-613
92. Pao CS, McKenzie SA. Randomized controlled trial of fluticasone in preschool children with intermittent wheeze. Am J Respir Crit Care Med 2002;166:945-949
93. Nielsen KG, Bisgaard H. The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children. Am J Respir Crit Care Med 2000;162:1500-1506
94. Chavasse RJ, Bastian-Lee Y, Richter H, Hilliard T, Seddon P. Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone. Arch Dis Child 2001;85: 143-148
95. Hofhuis W, van der Wiel EC, Nieuwhof EM, et al. Anti-Inflammatory Treatment in Infants with Recurrent Wheeze (AIR) Study Group: efficacy of fluticasone propionate on lung function and symptoms in wheezy infants. Am J Respir Crit Care Med 2005;171:328-333
96. Rodrigo GJ. Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. Am J Respir Crit Care Med 2005;171: 1231-1236
97. Estrada-Reyes E, Del Rio-Navarro BE, Rosas-Vargas MA, Nava-Ocampo AA. Co-administration of salbutamol and fluticasone for emergency treatment of children with moderate acute asthma. Pediatr Allergy Immunol 2005;16: 609-614
98. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006;354:1998-2005
99. Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet 2003;362:1433-1438
100. Bush A, Rubin BK. Macrolides as biologic response modifiers in cystic fibrosis and bronchiectasis. Semin Respir Crit Care Med 2003;24:737-747
101. Jaffe A, Bush A. Macrolides in cystic fibrosis. In: BK Rubin, J Tamaoki, eds. Progress in Inflammation Research: Antibiotics as Anti-inflammatory and Immunomodulatory Agents. Basel: Birkhauser Verlag; 2005:167-191
102. Yasui K, Agematsu K, Shinozaki K, et al. Theophylline induces neutrophil apoptosis through adenosine A2A receptor antagonism. J Leukoc Biol 2000;67:529-535
103. Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 2005; 172:364-370
104. Chen ST, Lu KH, Sun HL, Chang WT, Lue KH, Chou MC. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. Pediatr Allergy Immunol 2006;17: 49-54
105. Bisgaard H, Gillies J, Groenewald M, Maden C. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study. Am J Respir Crit Care Med 1999;160:126-131
106. Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002;87:457-461